Contact: Tom Hughes
tahughes@unch.unc.edu
919-966-6047
University of North Carolina Health Care

Study Justifies L-DOPA Therapy for Angelman Syndrome

Caption: This is an in vivo voltammograms showing higher dopamine (DA) release in the nucleus accumbens (NAc) and lower release in the dorsal striatum of Angelman syndrome model mice (Ube3a m-/p+) compared to wild-type mice (WT).

Credit: Image courtesy of C.J. Malanga, MD, PhD

Usage Restrictions: None

Related news release: Study justifies L-DOPA therapy for Angelman syndrome